![Kentaro Yoshimatsu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kentaro Yoshimatsu
Oprichter bij Rin Institute, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Yasushi Okada | M | 65 | 43 jaar | |
Sayoko Sasaki | F | 55 | 33 jaar | |
Kenta Takahashi | M | 64 | 41 jaar | |
Tatsuyuki Yasuno | M | 56 | 33 jaar | |
Masatomi Akana | M | 57 | 34 jaar | |
Lynn Kramer | M | 73 | 15 jaar | |
Hiroyuki Kato | M | 66 | 42 jaar | |
Yoshiteru Kato | M | 64 | 36 jaar | |
Teruyuki Masaka | M | 46 | 23 jaar | |
Terushige Iike | M | 60 | 38 jaar | |
Ivan Cheung | M | 47 | 19 jaar | |
Nobutake Morii | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Hiroko Kimura | M | - |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Yuji Yamada | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Takehiko Sawabe | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Masayoshi Miyanaga | M | 66 |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Takashi Owa | M | 61 | 33 jaar | |
Makoto Ohori | M | - |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Gary Bryan Hendler | M | 57 | 14 jaar | |
Shohei Kanazawa | M | 59 | 36 jaar | |
Yasuhiro Matsumura | M | - |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
Tetsuya Mishima | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Koji Hagimoto | M | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Japan | 66 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Kentaro Yoshimatsu
- Persoonlijk netwerk